Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01166074 · ClinicalTrials.gov registry record
Retrospective Chart Review of Subcutaneous IgG Use in Infants
A clinical trial, sponsored by CSL Behring.
- Completed
- Registry status
- 27
- Enrollment target
NCT01166074 is a clinical trial that has completed, run by CSL Behring. The registered enrollment target is 27 participants.
The verdict
NCT01166074 has completed, sponsored by CSL Behring.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
This study is a retrospective chart review of the use of subcutaneous IgG (SCIG) in infants less than two years old.
Interventions
- BIOLOGICAL Subcutaneous IgG (SCIG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2010-05 |
| Est. Completion | 2010-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01166074
The ClinicalTrials.gov registry entry for NCT01166074 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CSL Behring, which has 71 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Subcutaneous IgG (SCIG) is the first listed.
NCT01166074 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01166074 about?
NCT01166074 is a clinical study titled "Retrospective Chart Review of Subcutaneous IgG Use in Infants". This study is a retrospective chart review of the use of subcutaneous IgG (SCIG) in infants less than two years old.
What is the current status of trial NCT01166074?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2010-05. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01166074?
The interventions under investigation include: Subcutaneous IgG (SCIG) (BIOLOGICAL).
Who is sponsoring clinical trial NCT01166074?
This trial is sponsored by CSL Behring, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.